Bi-specific antibodies
Smithers, a bioanalytical CRO, understands the unique bioanalytical and regulatory challenges inherent to the development of bi-specific antibody therapeutics and has performed bioanalytical analysis for bi- and multi-specific antibodies at various stages of pre- and clinical development.